1. Home
  2. ATNM vs GDHG Comparison

ATNM vs GDHG Comparison

Compare ATNM & GDHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Actinium Pharmaceuticals Inc. (Delaware)

ATNM

Actinium Pharmaceuticals Inc. (Delaware)

HOLD

Current Price

$0.86

Market Cap

31.7M

Sector

Health Care

ML Signal

HOLD

Logo Golden Heaven Group Holdings Ltd.

GDHG

Golden Heaven Group Holdings Ltd.

HOLD

Current Price

$1.48

Market Cap

34.9M

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATNM
GDHG
Founded
2000
2008
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Services-Misc. Amusement & Recreation
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
31.7M
34.9M
IPO Year
2013
2022

Fundamental Metrics

Financial Performance
Metric
ATNM
GDHG
Price
$0.86
$1.48
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$4.50
N/A
AVG Volume (30 Days)
103.0K
66.4K
Earning Date
05-06-2026
07-11-2025
Dividend Yield
N/A
N/A
EPS Growth
14.17
N/A
EPS
N/A
N/A
Revenue
$90,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
11.11
N/A
52 Week Low
$0.88
$0.16
52 Week High
$1.81
$8.69

Technical Indicators

Market Signals
Indicator
ATNM
GDHG
Relative Strength Index (RSI) 35.93 48.63
Support Level N/A $1.06
Resistance Level $1.27 $1.67
Average True Range (ATR) 0.05 0.20
MACD -0.00 0.01
Stochastic Oscillator 2.53 40.46

Price Performance

Historical Comparison
ATNM
GDHG

About ATNM Actinium Pharmaceuticals Inc. (Delaware)

Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of targeted radiotherapies using its Antibody Radiation Conjugates (ARCs) platform, which combines monoclonal antibodies with radioisotopes to selectively target and destroy cancer cells. The company's product candidates include Iomab-B, an iodine-131 based radiotherapy for conditioning prior to hematopoietic stem cell transplantation, and Actimab-A, an actinium-225 based radiotherapy in clinical development for acute myeloid leukemia. The company is also advancing additional programs, including Iomab-ACT for cell and gene therapy conditioning and other preclinical candidates targeting solid tumors.

About GDHG Golden Heaven Group Holdings Ltd.

Golden Heaven Group Holdings Ltd is an offshore holding company. Through the operating entities in China, it manages and operates six properties consisting of amusement parks, water parks, and complementary recreational facilities. The parks offer a broad selection of exhilarating and recreational experiences, including both thrilling and family-friendly rides, water attractions, gourmet festivals, circus performances, and high-tech facilities. The firm's revenue is generated from selling access to rides and attractions, charging fees for special event rentals, and collecting regular rental payments from commercial tenants. it opearts in the Cayman Islands, PRC, BVI, and HK.

Share on Social Networks: